Jounce Therapeutics

+$0.44 (+6.09%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell JNCE and other stocks, options, and ETFs commission-free!

About JNCE

Jounce Therapeutics, Inc. Common Stock, also called Jounce Therapeutics, is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.

CEO
Richard Murray
Employees
128
Headquarters
Cambridge, Massachusetts
Founded
2013

JNCE Key Statistics

Market Cap
406.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
322.46K
High Today
$7.74
Low Today
$7.17
Open Price
$7.34
Volume
204.01K
52 Week High
$14.84
52 Week Low
$4.30

JNCE Earnings

-$0.82
$0.42
$1.66
$2.90
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.41 per share
Actual
-$0.58 per share
Replay Earnings Call

You May Also Like

WMG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure